PCAT6 and non-small cell lung carcinoma: In 2018, PCAT6 was found high-expressed in patients with non-small cell lung cancer (NSCLC), and the knockdown of PCAT6 showed a significantly inhibitory effect on the proliferation, migration and invasion of NSCLC cells [13].